A patient receiving an infusion will most likely remain in a sitting position on the table and will not necessarily need to change into a hospital gown
Novo Nordisk is advancing CagriSema toward commercial launch while also developing amycretin, a single-molecule dual GLP-1/amylin agonist that could eventually replace the two-injection CagriSema protocol with a single compound
But what exactly are these injections, and how do they work
For example, you may hear about a 2025 pilot study (considered preliminary research), which found that BPC-157 infusions were well-tolerated with no side effects
Peptides are short chains of amino acids linked together by peptide bonds, distinct from full proteins because they are much smaller but still specific enough to trigger a response once they attach to the right receptor
Who Tends to Do Better with Injections When the trouble is absorption rather than how much you're eating, a shot is usually the better fit